Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions-Reference-Cited by-同舟云学术

Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions

Published:2018-06 Issue:6 Volume:21 Page:707-714
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Wang Ting,McAuslane Neil,Liberti Lawrence,Leufkens Hubert,Hövels Anke

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference26 articles.

1. Assessing the relative efficacy of new drugs: an emerging opportunity;Eichler;Nat Rev Drug Discov,2015

2. Health technology assessment in Europe;Kristensen;Scand J Public Health,2009

3. A rational framework for decision making by the National Institute for Clinical Excellence (NICE);Claxton;Lancet,2002

4. Health economics and outcomes research within drug development

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel;GLOB REG HEALTH TECH;2024

2. Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel;Global and Regional Health Technology Assessment;2024-07-15

3. Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy;Health Research Policy and Systems;2024-07-02

4. Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned;Drug Discovery Today;2024-07

5. Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey;Value in Health;2024-07